CereneMayumana Healthcare is pleased to announce its exclusive distribution rights in the Netherlands for the Cerene® Cryotherapy Device from Channel Medsystems. This innovative, minimally invasive solution for treating heavy menstrual bleeding enables Mayumana Healthcare to make a significant impact on women’s health in the Netherlands.
Bart Verleg, CEO of Mayumana Healthcare, stated, “We are excited to introduce the Cerene® Cryotherapy Device as part of our portfolio for the Dutch market. Partnering with Channel Medsystems on this important launch aligns perfectly with our commitment to delivering pioneering healthcare solutions that cater to specific patient needs. With Cerene, we can offer women in the Netherlands a minimally invasive, safe, and effective treatment option for heavy menstrual bleeding, addressing a critical need in women’s health.”
Ric Cote, President and CEO of Channel Medsystems, echoed this sentiment, saying, “We are thrilled to partner with Mayumana Healthcare to bring the Cerene® Cryotherapy Device to women in the Netherlands. This collaboration reflects our shared commitment to improving women’s health through innovative, minimally invasive solutions. With Cerene, our mission is to empower women suffering from heavy menstrual bleeding by providing them with a safe, effective, and convenient treatment option that enhances their well-being and quality of life.”
This partnership underscores both companies’ commitment to advancing healthcare by making effective treatments more accessible to women, ultimately enhancing their autonomy and quality of life across the Netherlands. Mayumana also emphasizes its goal to lead in the gynecology field with cutting-edge medical technology.
About Mayumana Healthcare
Mayumana Healthcare is a provider of medical technology solutions with a specific focus on urology, gynecology, oncoloy, and neurosurgery. The company is dedicated to delivering innovative and high-quality products that contribute to patients’ well-being.
About Channel Medsystems
Channel Medsystems® is a privately-held company dedicated to empowering every woman to take control of her health journey and live her best life. With a commitment to deliver innovative technologies that exceed the expectations of women and their gynecologists, Channel strives to develop easy-to-use, safe, and cost-effective medical devices, resulting in exceptional outcomes and superior patient comfort that are accessible to all women. Channel Medsystems, Inc. is headquartered in Berkeley, CA.
For more information:
(+31) 252 23 58 00
info@myh.health
www.myh.health
Important Safety Information
Cerene® Cryotherapy Device is indicated to ablate the endometrial lining of the uterus in premenopausal women with heavy menstrual bleeding due to benign causes for whom childbearing is complete. Pregnancy following the Cerene procedure can be dangerous; therefore, contraception must be used until menopause. The Cerene procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. As with all surgical procedures, there are risks and considerations associated with the use of the Cerene Cryotherapy Device. Temporary side effects may include cramping, nausea, vomiting, vaginal discharge and spotting. For detailed benefit and risk information, consult the Cerene Instructions for use (IFU) or your healthcare professional. Learn More
